Coagulation factor binding orientation and dimerization may influence infectivity of adenovirus-coagulation factor complexes

Journal of Virology

Volumn 87, Issue 17, 2013, Pages 9610-9619

  Irons, Eric E ^a   Flatt, Justin W ^c   Doronin, Konstantin ^d   Fox, Tara L ^c   Acchione, Mauro ^b   Stewart, Phoebe L ^c   Shayakhmetov, Dmitry M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; GLUTAMIC ACID; PROTEOHEPARAN SULFATE; SERINE PROTEINASE; THREONINE;

ADENOVIRUS; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; COMPLEX FORMATION; CONTROLLED STUDY; DIMERIZATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; VIRUS ENTRY; VIRUS INFECTIVITY;

ADENOVIRUSES, HUMAN; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; FACTOR VII; FACTOR X; GENETIC VECTORS; HEK293 CELLS; HEPATOCYTES; HUMANS; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; VIRUS INTERNALIZATION;

EID: 84883277791     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01070-13     Document Type: Article

References (37)

1. Nemerow GR. 2000. Cell receptors involved in adenovirus entry. Virology 274:1-4.
2. Smith JG, Wiethoff CM, Stewart PL, Nemerow GR. 2010. Adenovirus. Curr. Top. Microbiol. Immunol. 343:195-224.
3. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
4. Roelvink PW, Lizonova A, Lee JG, Li Y, Bergelson JM, Finberg RW, Brough DE, Kovesdi I, Wickham TJ. 1998. The coxsackievirusadenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J. Virol. 72: 7909-7915.
5. Tomko RP, Xu R, Philipson L. 1997. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. U. S. A. 94:3352-3356.
6. Gaggar A, Shayakhmetov D, Lieber A. 2003. CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 9:1408-1412.
7. Segerman A, Atkinson JP, Marttila M, Dennerquist V, Wadell G, Arnberg N. 2003. Adenovirus type 11 uses CD46 as a cellular receptor. J. Virol. 77:9183-9191.
8. Wang HJ, Li ZY, Liu Y, Persson J, Beyer I, Moller T, Koyuncu D, Drescher MR, Strauss R, Zhang XB, Wahl JK, Urban N, Drescher C, Hemminki A, Fender P, Lieber A. 2011. Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat. Med. 17:96-104.
9. Arnberg N, Pring-Akerblom P, Wadell G. 2002. Adenovirus type 37 uses sialic acid as a cellular receptor on Chang C cells. J. Virol. 76:8834-8841.
10. Nilsson EC, Storm RJ, Bauer J, Johansson SMC, Lookene A, Angstrom J, Hedenstrom M, Eriksson TL, Frangsmyr L, Rinaldi S, Willison HJ, Domellof FP, Stehle T, Arnberg N. 2011. The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis. Nat. Med. 17:105-109.
11. Liu HR, Jin L, Koh SBS, Atanasov I, Schein S, Wu L, Zhou ZH. 2010. Atomic structure of human adenovirus by cryo-EM reveals interactions among protein networks. Science 329:1038-1043.
12. Reddy VS, Natchiar SK, Stewart PL, Nemerow GR. 2010. Crystal structure of human adenovirus at 3.5 angstrom resolution. Science 329:1071- 1075.
13. Akiyama M, Roelvink P, Einfeld D, Kovesdi I, King CR. 2003. Effect of ablating CAR and integrin binding on the biodistribution and cellular localization of adenovirus vectors following intravenous or intraperitoneal delivery. Mol. Ther. 7:S173.
14. Alemany R, Curiel DT. 2001. CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther. 8:1347- 1353.
15. Kalyuzhniy O, Di Paolo NC, Silvestry M, Hofherr SE, Barry MA, Stewart PL, Shayakhmetov DM. 2008. Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc. Natl. Acad. Sci. U. S. A. 105:5483-5488.
16. Parker AL, Waddington SN, Nicol CG, Shayakhmetov DM, Buckley SM, Denby L, Kemball-Cook G, Ni SH, Lieber A, McVey JH, Nicklin SA, Baker AH. 2006. Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 108:2554-2561.
17. Shayakhmetov DM, Gaggar A, Ni SH, Li ZY, Lieber A. 2005. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J. Virol. 79:7478-7491.
18. Waddington SN, Mcvey JH, Bhella D, Parker AL, Barker K, Atoda H, Pink R, Buckley SMK, Greig JA, Denby L, Custers J, Morita T, Francischetti IMB, Monteiro RQ, Barouch DH, van Rooijen N, Napoli C, Hlavenga MJE, Nicklin SA, Baker AH. 2008. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132:397-409.
19. Alba R, Bradshaw AC, Parker AL, Bhella D, Waddington SN, Nicklin SA, van Rooijen N, Custers J, Goudsmit J, Barouch DH, McVey JH, Baker AH. 2009. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 114:965-971.
20. Doronin K, Flatt JW, Di Paolo NC, Khare R, Kalyuzhniy O, Acchione M, Sumida JP, Ohto U, Shimizu T, Akashi-Takamura S, Miyake K, MacDonald JW, Bammler TK, Beyer RP, Farin FM, Stewart PL, Shayakhmetov DM. 2012. Coagulation factor X activates innate immunity to human species C adenovirus. Science 338:795-798.
21. Shayakhmetov DM, Lieber A. 2000. Dependence of adenovirus infectivity on length of the fiber shaft domain. J. Virol. 74:10274-10286.
22. Shayakhmetov DM, Papayannopoulou T, Stamatoyannopoulos G, Lieber A. 2000. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector. J. Virol. 74:2567-2583.
23. van Heel M, Gowen B, Matadeen R, Orlova EV, Finn R, Pape T, Cohen D, Stark H, Schmidt R, Schatz M, Patwardhan A. 2000. Single-particle electron cryo-microscopy: towards atomic resolution. Q. Rev. Biophys. 33:307-369.
24. Mindell JA, Grigorieff N. 2003. Accurate determination of local defocus and specimen tilt in electron microscopy. J. Struct. Biol. 142:334-347.
25. Saban SD, Silvestry M, Nemerow GR, Stewart PL. 2006. Visualization of alpha-helices in a 6-angstrom resolution cryoelectron microscopy structure of adenovirus allows refinement of capsid protein assignments. J. Virol. 80:12049-12059.
26. Grigorieff N. 2007. FREALIGN: high-resolution refinement of single particle structures. J. Struct. Biol. 157:117-125.
27. Banner DW, D'Arcy A, Chene C, Winkler FK, Guha A, Konigsberg WH, Nemerson Y, Kirchhofer D. 1996. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 380:41-46.
28. Eigenbrot C, Kirchhofer D, Dennis MS, Santell L, Lazarus RA, Stamos J, Ultsch MH. 2001. The factor VII zymogen structure reveals reregistration of beta strands during activation. Structure 9:627-636.
29. Perera L, Darden TA, Pedersen LG. 2002. Predicted solution structure of zymogen human coagulation FVII. J. Comput. Chem. 23:35-47.
30. Trabuco LG, Villa E, Mitra K, Frank J, Schulten K. 2008. Flexible fitting of atomic structures into electron microscopy maps using molecular dynamics. Structure 16:673-683.
31. Humphrey W, Dalke A, Schulten K. 1996. VMD: visual molecular dynamics. J. Mol. Graph. Model. 14:33-38.
32. Duffy MR, Bradshaw AC, Parker AL, Mcvey JH, Baker AH. 2011. A cluster of basic amino acids in the factorXserine protease mediates surface attachment of adenovirus/FX complexes. J. Virol. 85:10914-10919.
33. Rezaie AR. 2000. Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding. J. Biol. Chem. 275:3320-3327.
34. Martinez-Martinez I, Ordonez A, Pedersen S, de la Morena-Barrio ME, Navarro-Fernandez J, Kristensen SR, Minano A, Padilla J, Vicente V, Corral J. 2011. Heparin affinity of factor VIIa: implications on the physiological inhibition by antithrombin and clearance of recombinant factor VIIa. Thromb. Res. 127:154-160.
35. Yang L, Manithody C, Rezaie AR. 2002. Localization of the heparin binding exosite of factor IXa. J. Biol. Chem. 277:50756-50760.
36. Baker A, McVey JH, Waddington SN, Di Paolo NC, Shayakhmetov DM. 2007. The influence of blood on in vivo adenovirus bio-distribution and transduction. Mol. Ther. 15:1410-1416.
37. Chen CY, May SM, Barry MA. 2010. Targeting adenoviruses with factor X-single-chain antibody fusion proteins. Hum. Gene Ther. 21:739-749